Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Ischemic Necrosis: early-phase trial registry

1 of 2 indexed Ischemic Necrosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Ischemic Necrosis: 2 US clinical trials tracked, 1 recruiting.

Ischemic Necrosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 2 of these trials.

Enrollment posture brief

Registry condition ischemic-necrosis

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Ischemic Necrosis (this)50%
Open-enrollment share among volume-matched conditions near Ischemic Necrosis

Ischemic Necrosis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ischemic Necrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ischemic Necrosis is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Ischemic Necrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire Other
1 trials
Vertebral fracture analysis Other
1 trials
Dual-energy X-ray absorptiometry Other
1 trials
Alendronate Sodium Drug
1 trials

US sites by state

Facility locations filed on Ischemic Necrosis trials. A trial with sites in several states counts in each.

California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ischemic Necrosis page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemic Necrosis condition card totals 2 registered trials; most-linked intervention Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.